Bleeding out: Theranos oozes with corporate governance lessons
A year ago, Theranos was a Silicon Valley health tech “unicorn” praised for breakthrough advancements in blood testing. Now it’s under civil and criminal investigation for defrauding investors. The role Theranos’ board has played in this is already shaping up to be a pointed object lesson for board best practices ...
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
Article
LendingClub could teach Theranos a thing or two about crisis management
Relatively young, technology-based companies face special difficulties when dealing with crises. Their focus on market disruption and their lack of established credibility make earning public trust even more difficult. And yet, LendingClub shows how it can be done at a time when Theranos certainly failed the crisis management test. David ...
-
News BriefTesla turmoil, Kohls dismissal mark rare public rebukes of executive leadership
Two CEOs of high-profile American companies received rare public votes of no-confidence from their boards of directors this week, just as attendees at Compliance Week’s 20th Anniversary National Conference discussed their role in upholding business ethics and executive accountability.
-
AnalysisCompliance pros need guaranteed job protections when speaking truth to power
Too often, compliance professionals do their jobs only to receive a pink slip at the end. Panelists at Compliance Week’s 20th Anniversary National Conference in Washington, D.C. this week said compliance professionals need regular access and reporting lines to CEOs and boards of directors, and to feel free to speak ...